Bootstrap Bio, Inc.
PrivateLast Round
Seed
May 1, 2026
Total Funding Raised
$330,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Bootstrap Bio, Inc. is a biotechnology company focused on developing technology for the genetic editing of human embryos.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine
Business Model
B2C
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bootstrap Bio, Inc. Comparables
Compare Bootstrap Bio, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Preventive | 80% | |
| Origin Genomics | 77% | |
| Orchid Health | 71% | |
Bootstrap Bio, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 1, 2026 | ||||
| Pre Seed | Jul 1, 2024 |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2026
Completed a Seed funding round.
Bootstrap Bio, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Bootstrap Bio, Inc.'s valuation, stock price, and market status.